Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease (IPSG1)

• ClinicalTrials.gov Identifier: NCT02040714
• Recruitment Status: Enrolling by invitation
• First Posted: January 20, 2014
• Last Update Posted: October 25, 2021
• Sponsor: Texas Scottish Rite Hospital for Children
• Collaborators: Alberta Children's Hospital; Alfred I. duPont Hospital for Children; Le Bonheur Children's Hospital; Children's Hospital Colorado; Children's Hospital Los Angeles; Children's National Research Institute; Children's Healthcare of Atlanta; Children's Hospital of Philadelphia; Children's Hospital Medical Center, Cincinnati; Columbia University; Connecticut Children's Medical Center; Gillette Children's Specialty Healthcare; Boston Children's Hospital; Johns Hopkins University; Kaiser Permanente; Kasturba Medical College; Montefiore Medical Center; Nationwide Children's Hospital; NYU Langone Health; OrthoCarolina Research Institute, Inc.; University of Sao Paulo General Hospital; Seoul National University Childrens Hospital; Shriners Hospitals for Children; University Hospital Southampton NHS Foundation Trust; Baylor College of Medicine; Universitätsklinikum Hamburg-Eppendorf; Ann & Robert H Lurie Children's Hospital of Chicago; British Columbia Children's Hospital; Children's of Alabama; Hospital Infantil Universitario Niño Jesús, Madrid, Spain; University of Oklahoma; Oregon Health and Science University; Rady Children's Hospital, San Diego; San Jorge Children's Hospital (Puerto Rico); University College Dublin; Tianjin Children's Hospital; University Hospital Schleswig-Holstein; University of California, San Francisco; University of Haifa; Uppsala University
• Information provided by (Responsible Party): Harry Kim, MD, Texas Scottish Rite Hospital for Children

No Study Results Posted on ClinicalTrials.gov for this Study

• Recruitment Status: Enrolling by invitation
• Estimated Primary Completion Date: September 2032
• Estimated Study Completion Date: September 2032